Korro Bio Submits To Australian Alfred Health Human Ethics Committee To Start Phase 1/2 Clinical Study Of KRRO-121 To Treat Hyperammonemia In Patients With Urea Cycle Disorders

Benzinga Newsdesk www.benzinga.com Neutral 93.1%

Neg 0% Neu 93.1% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/1703647/000119312526356877/krro-20260819.htm

Comments

No comments yet. Be the first!